Listen here or on the go via Apple Podcasts and Spotify Pursuing social anxiety disorder with MDMA. Jason Najum talks to Srinivas Rao, CEO of Atai Life Sciences (NASDAQ:ATAI), a biotech company focused on mental health and psychedelic compounds (1:30). Standing on the shoulders of Johnson & Johnson's Spravato (4:00). Upcoming milestones and clinical trials (13:15). Psychedelic industry sentiment; RFK Jr influence (30:40). Transcript Jason Najum: Welcome to the Seeking Alpha podcast. I'm Jason Najum, Seek ...